Claim 55% Off TipRanks
- Unlock hedge fund-level data and powerful investing tools for smarter, sharper decisions
- Discover top-performing stock ideas and upgrade to a portfolio of market leaders with Smart Investor Picks
An update from Rubicon Research Limited ( (IN:RUBICON) ) is now available.
Rubicon Research Limited has allotted 341,815 fully paid-up equity shares of INR 1 each following the exercise of employee stock options under its 2022 Employee Stock Option Scheme. This allotment reflects the company’s ongoing use of equity-based incentives to reward and retain staff.
As a result of the ESOP exercise, Rubicon’s issued, subscribed and paid-up equity share capital has increased to INR 16,50,92,124, comprising an equal number of equity shares of face value INR 1 each. The change marginally dilutes existing shareholders but underscores the company’s commitment to aligning employee interests with long-term shareholder value.
More about Rubicon Research Limited
Rubicon Research Limited is an India-based company listed on BSE and NSE, operating in the pharmaceutical and life sciences research sector. The company develops and manufactures specialized drug formulations and related products, serving regulated markets with a focus on innovation-driven research and development.
Average Trading Volume: 19,050
Technical Sentiment Signal: Strong Buy
See more data about RUBICON stock on TipRanks’ Stock Analysis page.